An Analysis of Anthropometric Indicators and Modifiable Lifestyle Parameters Associated with Hypertensive Nephropathy

Table 5

Estimates of the prevalence of CKD in the study population using the renal function equations.

Parameter	4v-MDRD			CG			CKD-EPI
eGFR (mL/min/1.73 m^2)	Total	Control	Case	Total	Control	Case	Total	Control	Case
Stage 1 (≥90)	120 (49.80)	57 (93.40)	63 (35.00)	136 (56.40)	57 (93.40)	79 (43.90)	117 (48.50)	59 (96.70)	58 (32.20)
Stage 2 (60 to 89)	89 (36.90)	4 (6.60)	85 (47.20)	65 (27.00)	4 (6.60)	61 (33.90)	89 (36.90)	2 (3.30)	87 (48.30)
Stage 3 (30 to 59)	32 (13.30)	0 (0.00)	32 (17.80)	39 (16.20)	0 (0.00)	39 (21.70)	35 (14.50)	0 (0.00)	35 (14.50)
Stage 4 (15 to 29)	0 (0.00)	0 (0.00)	0 (0.00)	1 (0.40)	0 (0.00)	1 (0.60)	0 (0.00)	0 (0.00)	0 (0.00)
Stage 5 (<15)	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)
CKD (Stages 3 + 4 + 5)	32 (13.30)	0 (0.00)	32 (17.80)	40 (16.60)	0 (0.00)	40 (22.22)	35 (14.50)	0 (0.00)	35 (19.40)

Data is presented as absolute values with corresponding percentage in parenthesis. 4v-MDRD: four variable modification of diet in renal disease, CG: Cockcroft-Gault, CKD-EPI: chronic kidney disease epidemiology collaboration, eGFR: estimated glomerular filtration rate, and CKD: chronic kidney disease.